Joint pain affects millions of adults and often worsens with age as tissue repair capacity declines. Peptide therapy has emerged as a tool that addresses the underlying biology of joint repair rather than just masking pain. This guide covers the compounds most discussed for joint health, how they work, and how to think about incorporating them into a broader approach.
How peptides support joint repair
Unlike NSAIDs or cortisone injections that reduce inflammation short-term but do not address tissue repair, certain peptides work by supporting the body's own healing mechanisms. They promote angiogenesis (new blood vessel formation), collagen synthesis, and cellular repair processes that are essential for tendon, ligament, and cartilage recovery. Growth hormone optimization also plays a role in connective tissue maintenance over the long term.
Key compounds for joint health
BPC-157 (discuss with your physician)
BPC-157 (body-protective compound 157) is the most studied peptide for musculoskeletal repair. It has shown remarkable results in research for tendon, ligament, and cartilage injuries. It is not currently in Tides' standard compound lineup, but many patients discuss it with their prescribing physicians as part of an injury recovery conversation. If BPC-157 is something you want to explore, bring it to your physician's attention during your assessment.
Sermorelin for connective tissue support
Sermorelin supports growth hormone production, which plays a role in connective tissue maintenance, collagen synthesis, and long-term joint health. While it is not a direct joint repair compound, people using Sermorelin for anti-aging and body composition often notice improvements in joint comfort and recovery as a secondary benefit. Sermorelin is available through Tides as a physician-prescribed injectable.
NAD+ and cellular repair
NAD+ supports cellular energy production and DNA repair mechanisms that are relevant to tissue healing and inflammation regulation. While it is not a primary joint therapy, NAD+ is sometimes included in broader protocols for people managing chronic pain or slow recovery. It is available through Tides.
Glutathione for systemic inflammation
Glutathione reduces systemic oxidative stress and inflammation that contributes to joint discomfort and impaired recovery. While not a primary joint repair compound, it is commonly included in comprehensive protocols for people managing chronic inflammation. It is available through Tides as a physician-prescribed injectable.
Important: Joint pain that is severe, progressive, or related to a known structural injury requires evaluation by a physician or orthopedic specialist before starting any treatment. Peptides are not a replacement for surgery when surgery is clearly indicated.
Peptides by joint condition
| Condition | Most relevant compound | Typical protocol length |
|---|---|---|
| Tendinopathy and tendinitis | BPC-157 (discuss with physician) | 6 to 12 weeks |
| Ligament injuries | BPC-157 plus physician evaluation | 8 to 16 weeks |
| Age-related joint decline | Sermorelin for GH optimization | 3 to 6 months |
| General recovery support | NAD+ as part of broader protocol | Ongoing |
| Chronic inflammation | Glutathione for systemic oxidative stress | Ongoing |
How to get started through Tides
Start with a short health assessment online. It covers your health history, current symptoms, goals, and any medications or conditions. A licensed physician reviews your assessment the same day.
Your physician will determine which compounds are clinically appropriate for your situation. If you want to discuss BPC-157 specifically, note this during your assessment. Your physician will address it based on your health profile.
Prescriptions are filled at a licensed U.S. compounding pharmacy and shipped to your door. Your physician remains available throughout your protocol.
Setting realistic expectations
Weeks one to two: most people notice reduced inflammation and some pain relief. This is the anti-inflammatory effect of the protocol beginning to take hold. It is real but it is not structural repair yet.
Weeks three to six: improved strength and range of motion become noticeable. The joint begins to feel more stable. Physical therapy in this window tends to be more productive because the underlying tissue environment is improving.
Weeks eight to sixteen: meaningful structural improvement for moderate injuries. Tendons and ligaments that have been repairing consistently through this window show measurable functional improvement for most people.
Month four and beyond: chronic or severe conditions continue improving with consistent treatment and physical therapy. Peptide therapy works best as part of a comprehensive approach that includes physician oversight. Always consult your healthcare provider before starting.